Prognostic factors for pleural lymphoma patients

Area of Science:

• Oncology
• Hematology
• Immunology

Background:

• Pleural lymphocytic lymphoma can develop secondary to chronic tuberculous pyothorax.
• Identifying prognostic factors is crucial for patient management and treatment strategies.

Purpose of the Study:

• To evaluate prognostic factors in patients with pleural lymphocytic lymphoma associated with chronic tuberculous pyothorax.
• To determine factors influencing survival in this specific patient cohort.

Main Methods:

• Cox's proportional hazards model was used to analyze data from 47 patients.
• Patient data included demographics, disease stage, histology, and laboratory values (BUN, GPT).
• Immunologic and immunohistochemical studies were performed to confirm B-cell lymphomas.

Main Results:

• Poor performance status was significantly associated with shortened survival.
• Elevated blood urea nitrogen (BUN) and glutamic-pyruvic transaminase (GPT) levels were also linked to reduced survival.
• Performance status emerged as the most consistent prognostic factor compared to previous literature.

Conclusions:

• Performance status, BUN, and GPT levels are significant prognostic indicators for pleural lymphocytic lymphoma in patients with chronic tuberculous pyothorax.
• These factors suggest a marked deterioration in a patient's condition and impact survival.
• Performance status is a key factor in predicting survival for lymphocytic lymphoma, even when compared to other B-cell lymphomas.